ConductScience.org, home

Paper3955485

Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador.

Ratnam S and 2 others. CMAJ, 1986. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador. Papers, record 3955485. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3955485

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador.
PubMed
Journal
CMAJ
PubMed
Year
1986
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ratnam SS
2Head CBC B
3Butler RWR W

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis DMajor topic
Acute Disease
Adolescent
Adult
Carrier State
Child
Chronic Disease
Female
Hepatitis Antibodies
Hepatitis B
Hepatitis B Core Antigens
Hepatitis B Surface Antigens
Hepatitis B e Antigens
Hepatitis Delta Virus
Humans
Male
Middle Aged
Newfoundland and Labrador

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1835563Epidemiology of hepatitis B in two Alaska communities.Am J Epidemiol1977https://conductscience.org/library/papers/835563PubMed
24014206Antibodies to delta antigen in asymptomatic hepatitis B surface antigen-reactive blood donors in the United States and their association with other markers of hepatitis B virus.Am J Epidemiol1985https://conductscience.org/library/papers/4014206PubMed
37033398Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen.J Infect Dis1982https://conductscience.org/library/papers/7033398PubMed
46120275Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.Lancet1982https://conductscience.org/library/papers/6120275PubMed
56127458Influence of delta infection on severity of hepatitis B.Lancet1982https://conductscience.org/library/papers/6127458PubMed
67161596Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population.J Med Virol1982https://conductscience.org/library/papers/7161596PubMed
76413350The delta agent.Hepatology1983https://conductscience.org/library/papers/6413350PubMed
86696355Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela.Ann Intern Med1984https://conductscience.org/library/papers/6696355PubMed
96669568Epidemiology of delta infection in Scandinavia.Prog Clin Biol Res1983https://conductscience.org/library/papers/6669568PubMed
106706409Delta infection among patients with chronic hepatitis B in the Stockholm region.Infection1984https://conductscience.org/library/papers/6706409PubMed
116736942Delta agent infection in Melbourne.J Med Virol1984https://conductscience.org/library/papers/6736942PubMed
126383995Chronic delta hepatitis: a difficult problem for the hepatologist.Hepatogastroenterology1984https://conductscience.org/library/papers/6383995PubMed
136092192Antibody to the hepatitis B virus-associated delta-agent in immune serum globulins.Gastroenterology1984https://conductscience.org/library/papers/6092192PubMed
143979950Epidemiology and clinical impact of hepatitis D virus (delta) infection.Hepatology1985https://conductscience.org/library/papers/3979950PubMed
153922501Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/3922501PubMed
163998040Virology and clinical significance of delta agent infection.J Virol Methods1985https://conductscience.org/library/papers/3998040PubMed
176104036Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.Lancet1980https://conductscience.org/library/papers/6104036PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
35992619Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.Can Liver J2018https://conductscience.org/library/papers/35992619PubMed
35360523Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada.JHEP Rep2022https://conductscience.org/library/papers/35360523PubMed
22346420Estimation of the secondary attack rate for delta hepatitis coinfection among injection drug users.Can J Infect Dis1993https://conductscience.org/library/papers/22346420PubMed
18159362Chronic hepatitis B infection in Canada.Can J Infect Dis2001https://conductscience.org/library/papers/18159362PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3955485

GET https://conductscience.org/api/papers/v1/3955485/authors